Zhenyi Xu
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A bidirectional interpretable compound-protein interaction prediction framework based on cross attention.
Journal: Computers in biology and medicine
Published: August 31, 2023
Biologically Interpretable Deep Learning To Predict Response to Immunotherapy In Advanced Melanoma Using Mutations and Copy Number Variations.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: October 20, 2022
HiRAND: A novel GCN semi-supervised deep learning-based framework for classification and feature selection in drug research and development.
Journal: Frontiers in oncology
Published: September 18, 2022
E2EFP-MIL: End-to-end and high-generalizability weakly supervised deep convolutional network for lung cancer classification from whole slide image.
Journal: Medical image analysis
Published: April 27, 2022
Characterization of the Immune Cell Infiltration Landscape Uncovers Prognostic and Immunogenic Characteristics in Lung Adenocarcinoma.
Journal: Frontiers in genetics
Published: March 23, 2022
Improving ovarian cancer treatment decision using a novel risk predictive tool.
Journal: Aging
Published: February 10, 2022
The Discovery of New Drug-Target Interactions for Breast Cancer Treatment.
Journal: Molecules (Basel, Switzerland)
Published: November 22, 2021
Identification and validation of cellular senescence patterns to predict clinical outcomes and immunotherapeutic responses in lung adenocarcinoma.
Journal: Cancer cell international
Published: October 15, 2021
Cross-talk of pyroptosis and tumor immune landscape in lung adenocarcinoma.
Journal: Translational lung cancer research
Published: July 07, 2021
Mediation Analysis Reveals Potential Biological Mechanism of Ascites Influencing Recurrence in Patients with Epithelial Ovarian Cancer.
Journal: Cancer management and research
Published: September 24, 2019
Last Updated: 09/26/2026